Viaflo Containers
VIAFLO CONTAINERS FOR OPTIMAL FLUID DELIVERY
Easy to use, versatile and efficient, Viaflo intravenous (IV) bags offer many advantages that support clinicians in providing optimal IV therapy delivery.
COLLAPSIBLE CLOSED-SYSTEM DESIGN
With its closed-system design, the Viaflo container does not need to be vented, which prevents the introduction of external contaminants that air filters might not remove, helping to minimise bloodstream infection risk.1,2 As a fully collapsible closed system, it helps ensure that the patient receives the intended prescribed dose by minimising residual volume.3,4 It also minimises air volume, so that the bag collapses without wrinkling, and maximises admixture volume to reduce manipulation when adding drugs.5
VERSATILITY
Viaflo containers are versatile, giving clinicians flexibility across Baxter’s fluid portfolio to help meet patient needs. Available in five sizes and constructed of three layers, Viaflo bags minimise interaction between container and solution, so they are compatible with many additives, with less leaching and adsorption.
EASE OF USE
Ease of use is yet another advantage of Viaflo IV bags. They feature an overwrap to protect the Viaflo container, a large pre-cut hanger, a dedicated administration port with a twist-off protector, and a dedicated, rigid medication port to lessen the risk of needle-stick injuries. The die-stamped permanent label clearly identifies the product type and format and includes a scannable bar code.
SUSTAINABILITY
Baxter has taken steps to position Viaflo containers high on the sustainability index by using renewable energy and energy-efficient practices in manufacturing, reducing transportation distances and decreasing packaging and waste.6
Prescribing Information for 0.9% Sodium Chloride (UK & ROI).
Adverse Events and any drug or medical device product quality complaints (including suspected defective medicines or medical device adverse incidents) should be reported.
- For the UK reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
- For Ireland report to the Health Products Regulatory Authority (HPRA) using a Yellow Card obtained from the HPRA, via the online system (www.hpra.ie) or by telephone on +353 (0)1-6764971.
- Adverse Events relating to Baxter products can also be reported direct to Baxter Pharmacovigilance on +44 (0)1635 206360, or by email to [email protected].
- Drug or medical device product quality complaints relating to Baxter products can be reported directly to Baxter Healthcare Ltd:
- In the UK +44 (0)1604 704603, or by email to [email protected].
- In Ireland on +353 (0)1 2065500 or by email to [email protected].
- Alternatively please report directly to your Baxter Representative, who will take the details and forward to the Baxter Country Quality Assurance Team.
Rx only. For safe and proper use of the product mentioned herein, please refer to the appropriate Operator's Manual or Instructions for Use.
Baxter and Viaflo are trademarks of Baxter International Inc. or its subsidiaries.